Navigation Links
Insmed Inc. to Present at C.E. Unterberg, Towbin Growth Conference

RICHMOND, VA., July 9 /CNW/ - Insmed Inc. (NASDAQ:INSM), a biopharmaceutical company focused on the development and approval of drugs for the treatment of metabolic diseases with unmet medical needs, today announced that it will present at this week's C.E. Unterberg, Towbin (CEUT) Emerging Growth Opportunities Conference in New York City.

The conference, to be held at the Mandarin Oriental Hotel in New York City, will run from Tuesday, July 10th through Thursday, July 12th. Dr. Geoffrey Allan, Ph.D., Insmed's President and CEO, will make the presentation on Thursday, July 12th at 8:30 a.m.; the Company will also hold one-on-one meetings with investment firm representatives. A live video Webcast of the presentation will be available at the investor relations section of Insmed's website, http://www.insmed.com.

Dr. Allan said, "We are especially pleased to be participating in this year's CEUT conference, because it gives us an ideal forum to present our dual strategy growth plan, based on our approved proprietary protein platform and the development and manufacture of follow-on biologics, to a crucial audience of investment managers and analysts. Insmed has a very timely story to tell, and we are glad to get this opportunity to tell it at such a high-visibility event."

About Insmed

Insmed is a biopharmaceutical company focused on the development and approval of drugs for the treatment of metabolic diseases with unmet medical needs. For more information please visit http://www.insmed.com.

Forward Looking Statements: This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in th
'"/>




Page: 1 2

Related medicine technology :

1. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
2. Insmed Announces Promising Results From IPLEX Phase II Myotonic Muscular Dystrophy Clinical Study
3. Insmed Releases Positive Results from Iplex Phase II HIV-Associated Adipose Redistribution Syndrome Clinical Study
4. The Past, Present and Future of HLA Typing
5. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
10. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
11. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Insmed Inc Present Unterberg Towbin Growth Conference
(Date:11/29/2009)...ire/ -- Radiologists can accurately diagnose acute...of a handheld device or mobile phone equipped with...today at the annual meeting of the Radiological So... to improve the speed and accuracy of medical diag...different consulting physicians," said the study,s...
(Date:11/29/2009)...ire/ -- Middle-aged men and women who engage in hi...causing damage to their knees and increasing their...sented today at the annual meeting of the Radiolog...ata suggest that people with higher physical activ...nee abnormalities and, thus, at higher risk for de...
(Date:11/29/2009)...ire/ -- Elastography is an effective, convenient t...lps distinguish cancerous breast lesions from beni...d today at the annual meeting of the Radiological ...raphy yields suspicious findings, physicians often...However, ultrasound has the potential to result in...
Breaking Medicine Technology:Smart Phones Allow Quick Diagnosis of Acute Appendicitis 2Smart Phones Allow Quick Diagnosis of Acute Appendicitis 3Too Much Physical Activity May Lead to Arthritis 2Too Much Physical Activity May Lead to Arthritis 3Elastography Reduces Unnecessary Breast Biopsies 2Elastography Reduces Unnecessary Breast Biopsies 3ESRI Health GIS Conference to Feature Speakers Innovating Health Care 47799 1ESRI Health GIS Conference to Feature Speakers Innovating Health Care 47799 2ESRI Health GIS Conference to Feature Speakers Innovating Health Care 47799 3ESRI Health GIS Conference to Feature Speakers Innovating Health Care 47799 4Purple Communications 28TM 29 Launches Dream Bigger Initiative Celebrating the Stories Culture and Heritage of Americas Deaf and Hard of Hearing Com 47795 1Purple Communications 28TM 29 Launches Dream Bigger Initiative Celebrating the Stories Culture and Heritage of Americas Deaf and Hard of Hearing Com 47795 2Purple Communications 28TM 29 Launches Dream Bigger Initiative Celebrating the Stories Culture and Heritage of Americas Deaf and Hard of Hearing Com 47795 3Purple Communications 28TM 29 Launches Dream Bigger Initiative Celebrating the Stories Culture and Heritage of Americas Deaf and Hard of Hearing Com 47795 4Purple Communications 28TM 29 Launches Dream Bigger Initiative Celebrating the Stories Culture and Heritage of Americas Deaf and Hard of Hearing Com 47795 5Purple Communications 28TM 29 Launches Dream Bigger Initiative Celebrating the Stories Culture and Heritage of Americas Deaf and Hard of Hearing Com 47795 6Angiotech Enters License Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation 12448 1Angiotech Enters License Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation 12448 2Angiotech Enters License Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation 12448 3Angiotech Enters License Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation 12448 4Angiotech Enters License Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation 12448 5Angiotech Enters License Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation 12448 6
... AML, Including Those with Poorest Prognoses , ...rth America today announced data from a Phase II t...en(R) (decitabine for injection) in acute myeloid ... The study involved elderly patients with AML, who...nd are typically considered ineligible for standar...
...euticals,Inc. (Nasdaq: ALXN ) today reported pos...on study examining Soliris(R) (eculizumab) treatme...hemoglobinuria (PNH). The pre-specified,primary ef...d with an 86,percent reduction (P<0.001). Key s...and transfusions/anemia (P<0.001) were also ach...
Other Medicine Technology:Dacogen(R) (decitabine for injection) Data Presented on a Phase II Clinical Trial in Elderly Patients with Acute Myeloid Leukemia (AML) 2Dacogen(R) (decitabine for injection) Data Presented on a Phase II Clinical Trial in Elderly Patients with Acute Myeloid Leukemia (AML) 3Dacogen(R) (decitabine for injection) Data Presented on a Phase II Clinical Trial in Elderly Patients with Acute Myeloid Leukemia (AML) 4Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 2Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 3Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 4Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 5Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 6Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 7Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 8
(Date:11/29/2009)..., Nov. 29 The following is an inve...ities Research, Inc. ,, Intellivest Securities ...tment advisor, has published a Report on BioClinic...maceutical, biotechnology and medical device indus... manage, process and submit medical imaging portio...
(Date:11/29/2009)...mannequins to teach doctors-in-training how to do ...o improve their skills without compromising patien...enry Ford Hospital. , The study shows that this ... tool to improve medical residents, knowledge, dex...ore common ultrasound-guided procedures, including...
(Date:11/29/2009)...ON, Minn., Nov. 29 Acuo Technologi...anagement software, data migration tools and servi... AcuoShare that allows image sharing across the ne..., The AcuoShare solution is based on the versatil...re. The Acuo AcuoShare enables secure access from...
(Date:11/29/2009)...,300 round of treatment equals a $41,000 pay raise...(HealthDay News) -- Psychological therapy may be m...ting a raise or winning a lottery prize, suggests ...n thousands of people who provided information abo...ease in happiness from a $1,329 course of therapy ...
(Date:11/29/2009)... "The YogaForce A-Line Athletic Mat is g...rew Weil, M.D., author and physician best known fo...rative medicine. Go to www.yogaforce.com and or...e gift list. , San Franci...for the holidays, the YogaForce newly patented, re...
Breaking Medicine News(10 mins):Health News:Research Report on BioClinica, Inc. as Speculative Buy 2Health News:Simulated training for ultrasound-guided procedures improves safety without risk to patients 2Health News:Acuo Technologies Announces a New Offering That Enables Sharing of Imaging Studies Securely and Affordably 2Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3
...a nursing home in the Victorian state of Australia...Opposition parties in Victoria have slammed her ha...es have been lost till now. The state is situat...ng of the issue as an "extraordinary failure of p...
... Health (HSPH) and the Association of European Can...door smoking bans in countries across the globe. T...ve indoor smoking ban as a likely tipping point fo...opted national indoor smoke-free policies that are...
...an Academy of Otolaryngology – Head and Neck Surge...pe with the pollen in the air, and how an ear, nos...ring, pollen from blooming trees and plants will j...imes headache. This year, some areas are re portin...
... would struggle to cope under a sudden surge of pa... trauma and emergency specialists.// At pre...r Australasian hospitals, says Dr Anthony Joseph, ...published their study on whether Australasian publ...
... to humans, scientists warn. The probability is hi...,// out of which one ended in death. Following th...need for better controls and checks to be institut...sed due to person-to-person contact. Change...
...ing stranger than fiction. In a first-ever, scie.../ human sperms from a source far removed from it...arrow are now the new ‘fathers’ of immature sperms...d Münster and the Medical School of Hannover say t...
Other Medicine News:Health News:Australian State Health Official Sacked Following Poisoning Outbreak in Nursing Home 2Health News:Global Momentum for Smoke-Free Indoor Environments at Tipping Point 2Health News:April Showers Bring May Flowers – And Plenty of Pollen, To 2Health News:Can Our Hospitals Cope In A Disaster? 2Health News:Breakthrough Discovery- Human Sperms From Bone Marrow 2
...gital offers improved ergonomics for today's exact...ied grippy finger rest and the large display windo...pette Digitals also feature soft-touch tip ejectio...) and super blow-out for 0.2 - 50ul micro volume p...
...0i is the first Sysmex hematology analyzer designe...ents. With its small footprint, closed tube sampli...ole blood sample, you have a solution for any smal...rgical suite, or small clinic. The differential on...
...aker family, which includes the world's smallest d...e most advanced pacemaker technology available, in..., the first and only U.S. commercially approved al...AF). The AF Suppression algorithm in the Identity ...
IntelliVue Information Center
Medicine Products: